Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Ratios and Metrics

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q3 2024 Q1 2024 Q4 2023
Period Ending Mar 31, 2025 Sep 30, 2024 Mar 31, 2024 Dec 31, 2023
PE Ratio
-0.8 n/a -12.52 n/a
PEG Ratio
n/a n/a n/a n/a
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.51 n/a n/a n/a
P/FCF Ratio
-4.37 n/a -37.73 n/a
P/OCF Ratio
-4.37 n/a -37.73 n/a
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a -0.1 n/a n/a
Quick Ratio
14.31 0.16 n/a 0.85
Current Ratio
14.31 0.16 n/a 0.85
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-7.18 n/a -32.86 -88.82
Return on Equity
-0.16 n/a n/a 0.08
Return on Assets
-0.1 n/a n/a -1.04
Return on Invested Capital
-0.11 n/a n/a 5.69
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a